<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02665494</url>
  </required_header>
  <id_info>
    <org_study_id>BI-CAUSE</org_study_id>
    <nct_id>NCT02665494</nct_id>
  </id_info>
  <brief_title>Biliary Cancer in Italy: a Study on Cholangiocarcinoma cAUSEs and Risk Factors</brief_title>
  <official_title>Biliary Cancer in Italy: a Study on Cholangiocarcinoma cAUSEs and Risk Factors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondazione del Piemonte per l'Oncologia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondazione del Piemonte per l'Oncologia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Multi-centric, observational, prospective study, designed for pts with diagnosis of
      all-stages cholangiocarcinoma, including rare and crossing-over histological types, and
      excluding gallbladder cancer and ampullary carcinoma.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will undergo basal blood sample exams regarding blood cell count, renal and liver
      function, tumor markers, inflammatory and metabolic state, along with a screening (and, if
      needed, a more in-depth laboratory analysis) for viral hepatitis infections. Information will
      be collected about radiological, clinical and pathological features of the neoplasm at time
      of diagnosis, as well, at a later time, about its natural history. A two-step data analysis
      will be performed: Task-1 analysis will define the risk factors landscape, Task-2 analysis
      will examine the influence of etiology on clinical outcomes. Anonymized data will be stored
      in a central database, kept at the Leading Centre.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>assessment the prevalence of a broad pool of medical or non-medical (e.g. life-style) conditions among Italian patients with cholangiocarcinoma, in order to evaluate their potential role as a risk factor</measure>
    <time_frame>36 months</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Cholangiocarcinoma</condition>
  <eligibility>
    <study_pop>
      <textblock>
        patients with diagnosis of all-stages cholangiocarcinoma, including rare and crossing-over
        histological types, and excluding gallbladder cancer and ampullary carcinoma
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  voluntary, written, dated and signed informed consent;

          -  age ≥ 18 years;

          -  histologically documented diagnosis of cholangiocarcinoma (including histological
             variants and mixed forms). Neoplasms under investigation do not include gallbladder
             cancer and ampullary carcinoma.

        Exclusion Criteria:

          -  Dementia or altered mental status leading to inability to understand or render the
             informed consent.

          -  Patients who already underwent a systemic treatment (chemotherapy and/or targeted
             therapy) may be enrolled but will not be subject to data collection about BI-CAUSE -
             Study Protocol Version 1.0 Oct 18th, 2015 10 blood laboratory tests (with the
             exception of viral screening) and natural history, and will not be factored in the
             data analysis of prognostic factors. Performance status, life expectancy, tumour
             staging, tumour site (distal or hilar extrahepatic, intrahepatic), previous surgical
             resection, previous biliary stenting, previous radiotherapy are not part of
             inclusion/exclusion criteria.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francesco Leone, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IRCCS Candiolo</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Celeste Cagnazzo, PhD</last_name>
    <phone>00390119933851</phone>
    <email>celeste.cagnazzo@ircc.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Fondazione del Piemonte per l' Oncologia - IRCCS Candiolo</name>
      <address>
        <city>Candiolo</city>
        <state>Torino</state>
        <zip>10127</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Celeste Cagnazzo, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Istituto Tumori Giovanni Paolo II Bari - IRCCS</name>
      <address>
        <city>Bari</city>
        <zip>70124</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nicola Silvestris, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Sant'Orsola Malpighi</name>
      <address>
        <city>Bologna</city>
        <zip>40138</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera S.Croce e Carle Cuneo</name>
      <address>
        <city>Cuneo</city>
        <zip>12100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vincenzo Ricci, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Istituto Oncologico Veneto - IRCCS</name>
      <address>
        <city>Padova</city>
        <zip>35128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sara Lonardi, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Santo Spirito di Pescara</name>
      <address>
        <city>Pescara</city>
        <zip>65124</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Carlo Garufi, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero-Universitaria Pisana</name>
      <address>
        <city>Pisa</city>
        <zip>56126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lorenzo Fornaro, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Policlinico Universitario Campus Bio-Medico</name>
      <address>
        <city>Rome</city>
        <zip>00128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Daniele Santini, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Istituto Nazionale Tumori Regina Elena</name>
      <address>
        <city>Rome</city>
        <zip>00144</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michele Milella, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>AOU Città della Salute e della Scienza di Torino - Ospedale Molinette</name>
      <address>
        <city>Turin</city>
        <zip>10126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Libero Ciuffreda, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>AO Ordine Mauriziano di Torino</name>
      <address>
        <city>Turin</city>
        <zip>10128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Elisa Sperti, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero-Universitaria di Udine</name>
      <address>
        <city>Udine</city>
        <zip>33100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Giuseppe Aprile, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 24, 2016</study_first_submitted>
  <study_first_submitted_qc>January 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 27, 2016</study_first_posted>
  <last_update_submitted>September 22, 2016</last_update_submitted>
  <last_update_submitted_qc>September 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 23, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholangiocarcinoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

